26.11.2021 • News

Linde and KazMunayGas in Clean Energy Pact

German industrial gases and technology company Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned oil and gas group KazMunayGas to jointly develop clean energy projects.

The first stage of cooperation will focus on exploring the opportunity to produce hydrogen and ammonia in Kazakhstan, using natural gas as feedstock and/or electrolysis (blue/green hydrogen and blue/green ammonia). Once the companies complete a feasibility study and successfully reach agreement, they will move forward with building a hydrogen/ammonia plant. They did not give a timescale for the project.

KazMunayGas has a consistent and balanced approach to decarbonization projects as part of its adopted Low-Carbon Development Program. Cooperation with the world’s leading companies is a priority in studying promising projects in this area,” said Alik Aidarbayev, chairman of the management board at KazMunayGas.

Linde formed a joint venture with ITM Power in January 2020 to provide industrial-scale green gas project services. ITM Linde Electrolysis combines ITM Power’s modular proton exchange membrane electrolyzer technology with Linde’s engineering, procurement and construction expertise.

Author: Elaine Burridge, Freelance Journalist

Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned...
Linde has signed a Memorandum of Understanding with Kazakhstan’s state-owned oil and gas group KazMunayGas to explore the feasibility of producing hydrogen and ammonia in Kazakhstan, using natural gas as feedstock and/or electrolysis (blue/green hydrogen and blue/green ammonia). (c) Linde

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read